Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Racine-Poon

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biometrics|December 1, 1987
A two-stage procedure for bioequivalence studiesA Racine-Poon, A P Grieve, H Flühler, et al.
European Journal of Clinical Pharmacology|April 29, 1998
An interaction study with cimetidine and the new angiotensin II antagonist valsartanE K Schmidt, K H Antonin, G Flesch, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjectsP Müller, T Cohen, M de Gasparo, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III studyH Schmidli, B Peng, G-J Riviere, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biometrics|December 1, 1987
A two-stage procedure for bioequivalence studiesA Racine-Poon, A P Grieve, H Flühler, et al.
European Journal of Clinical Pharmacology|April 29, 1998
An interaction study with cimetidine and the new angiotensin II antagonist valsartanE K Schmidt, K H Antonin, G Flesch, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjectsP Müller, T Cohen, M de Gasparo, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III studyH Schmidli, B Peng, G-J Riviere, et al.
Clinical Pharmacology and Therapeutics|January 20, 1998
Efficacy, pharmacodynamics, and pharmacokinetics of CGP 51901, an anti-immunoglobulin E chimeric monoclonal antibody, in patients with seasonal allergic rhinitisA Racine-Poon, L Botta, T W Chang, et al.
Pageof 2